Metsera Inc. (NASDAQ:MTSR) hit a record high on Thursday amid a bidding war between Pfizer and Novo Nordisk. Novo Nordisk offered $8.5 billion, surpassing Pfizer's $7.3 billion. Pfizer plans to sue for breach of agreement.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing